Kolexia
Blanchard Pierre Oncologie radiothérapie
Blanchard Pierre
Oncologie radiothérapie
Gustave-Roussy
Villejuif, France
870 Activités
6.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs de la tête et du cou Tumeurs de la prostate Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de l'oropharynx Récidive tumorale locale Tumeurs du rhinopharynx Cancer du nasopharynx

Collaborateurs

Voir plus
Tao Yungan
Tao Yungan
Gustave-Roussy, Villejuif, France
Temam Stephane
Temam Stephane
Gustave-Roussy, Villejuif, France
Bossi Alberto
Bossi Alberto
Gustave-Roussy, Villejuif, France
Bourhis Jean
Bourhis Jean
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Bayer
19 collaboration(s)
Dernière en 2023
Ipsen
6 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023
Merck-Serono
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer: Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
Essai Clinique (M.D. Anderson Cancer Center)   11 mars 2024
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer: Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Essai Clinique (M.D. Anderson Cancer Center)   06 mars 2024
SABRE: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
Essai Clinique (Boston Scientific)   26 février 2024
TEMPOS: Erectile Dysfunction in Good Prognosis Prostate Cancer: a Phase III Medico-economic Study Comparing Brachytherapy to Stereotactic Body Radiotherapy
Essai Clinique (Centre Eugène Marquis)   06 février 2024
BLAD-RAD01: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   01 février 2024
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   11 novembre 2023
Pr Pierre Blanchard - Cancers ORL / Quelle place pour des thérapies ciblées EGFR ?
Youtube @ Gustave Roussy   25 octobre 2023
857O MACH-EGFR: Individual patient data (IPD) meta-analysis of anti-EGFR monoclonal antibodies (Ab) in patients (pts) with locally advanced (LA) squamous cell carcinomas of head and neck (SCCHN)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Incorporating absolute effects to enrich interpretation of findings from meta-analyses - Authors' reply.
The Lancet. Oncology   04 septembre 2023
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.
European urology   31 août 2023